Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1097-1108
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1097
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1097
Table 1 Baseline characteristic and clinical outcomes of included patients
| Factor | Value |
| N | 6526 |
| Postoperative VTE within 30 d (%) | 49 (0.8) |
| Age, median (IQR) | 44 (36.1, 52.81) |
| Age > 50 yr (%) | 2083 (31.9) |
| Female gender (%) | 5282 (80.9) |
| Preop GERD requiring medication (%) | 2477 (38.0) |
| Preop history of MI (%) | 67 (1.0) |
| Previous PCI (%) | 140 (2.1) |
| Previous cardiac surgery (%) | 48 (0.7) |
| Preop hypertensive requiring medication (%) | 3340 (51.2) |
| Preop hyperlipidemia (%) | 1691 (25.9) |
| Preop weight closest to bariatric surgery, median (IQR) | 287 (256, 329) |
| Preop BMI closest to bariatric surgery, median (IQR) | 47.61 (44.26, 51.75) |
| Preop vein thrombosis (%) | 128 (2.0) |
| Preop venous stasis (%) | 195 (3.0) |
| Preop requiring or on dialysis (%) | 7 (0.1) |
| Preop renal insufficiency/CKD (%) | 56 (0.9) |
| Preop therapeutic anticoagulation (%) | 201 (3.1) |
| Previous foregut surgery (%) | 710 (10.9) |
| Current smoker within 1 yr (%) | 546 (8.4) |
| Preop history of COPD (%) | 126 (1.9) |
| Preop obstructive sleep apnea | 3196 (49.0) |
| Preop steroid/immunosuppressant use for chronic condition (%) | 113 (1.7) |
| Preop history of IVC filter placement (%) | 25 (0.4) |
| Preop history of DM (%) | 2009 (30.8) |
| Preop albumin (g/dL), median (IQR) | 3.9 (3.4, 4.2) |
| Preop serum creatinine (mg/dL), median (IQR) | 0.77 (0.69, 0.85) |
| Preop hematocrit (%), median (IQR) | 40.3 (37.7, 42.8) |
| Preop hemoglobin A1c > 7% | 741 (11.4) |
Table 2 The proposed prediction model for 30-d risk of venous thromboembolism in patients undergoing Roux-en-Y gastric bypass
| Variables | Regression coefficient | Standard error | t value | P value | 95% confidence interval (lower) | 95% confidence interval (upper) |
| Preoperative COPD | 2.54 | 0.49 | 5.15 | 0 | 1.57 | 3.51 |
| Length of stay | 0.08 | 0.01 | 6.24 | 0 | 0.06 | 0.11 |
| Deep vein thrombosis history | 1.62 | 0.67 | 2.42 | 0.02 | 0.31 | 2.92 |
| Hemoglobin A1c level | 1.19 | 0.34 | 3.47 | 0 | 0.52 | 1.86 |
| History of venous stasis | 1.44 | 0.53 | 2.7 | 0.01 | 0.4 | 2.48 |
| Preoperative anticoagulation use | 1.24 | 0.63 | 1.97 | 0.05 | 0.01 | 2.48 |
| Model constant | -5.77 | 0.28 | -20.61 | 0 | -6.32 | -5.22 |
- Citation: Ali H, Inayat F, Moond V, Chaudhry A, Afzal A, Anjum Z, Tahir H, Anwar MS, Dahiya DS, Afzal MS, Nawaz G, Sohail AH, Aziz M. Predicting short-term thromboembolic risk following Roux-en-Y gastric bypass using supervised machine learning. World J Gastrointest Surg 2024; 16(4): 1097-1108
- URL: https://www.wjgnet.com/1948-9366/full/v16/i4/1097.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i4.1097
